A college student in Reading, Berkshire has died from meningitis, with two others currently undergoing treatment for the disease. The outbreak underscores the importance of recognizing meningitis symptoms early, as the infection progresses rapidly.
Meningitis causes inflammation of the membranes surrounding the brain and spinal cord. Symptoms develop quickly over hours and include high fever, severe headache, stiff neck, sensitivity to light, nausea, vomiting, confusion, and a rash that doesn't fade under pressure. In infants, signs include fever, irritability, difficulty feeding, and an unusual cry.
Two types cause most meningitis cases: bacterial and viral. Bacterial meningitis proves more serious and requires immediate antibiotic treatment. Viral meningitis typically resolves on its own but still demands medical evaluation. Both require emergency care; meningitis kills within 24 to 48 hours without treatment.
Vaccines provide protection against several meningitis-causing bacteria. The meningococcal conjugate vaccine (MenACWY) protects against serogroups A, C, W, and Y. The serogroup B vaccine (MenB) covers another dangerous strain. In the UK, the NHS offers both vaccines to teenagers and young adults, with MenB particularly recommended for college students and those in shared accommodation. High-risk groups including people with certain immune conditions or those without a spleen also qualify for vaccination.
Vaccination coverage remains important since meningococcal disease clusters can occur in close-contact settings like university halls. One dose of MenACWY provides long-term protection, though booster doses may be needed for certain risk groups. MenB typically requires two doses several weeks apart.
Anyone experiencing symptoms should seek emergency medical care immediately. Early diagnosis and treatment with antibiotics significantly improve outcomes. Close contacts